IP Library Granted Patent US 10,723,764
Granted Patent B2
US 10,723,764 · App. 14/700,908 · Granted Jul 28, 2020

Anti-microbial peptides and methods of use thereof

Inventor: Guangshun Wang (Omaha, NE)
Assignee: BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
C07K7/08A61K45/06A61K38/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,723,764
App. No.
14/700,908
Granted
Jul 28, 2020
Kind
B2
Abstract

Anti-microbial peptides and methods of use are provided.

Claims (14)

1. An isolated anti-microbial peptide comprising the amino acid sequence GX 1 KRLVQRLKDX 2 LRNLV (SEQ ID NO: 58); wherein X 1 and X 2 are hydrophobic amino acids; wherein said peptide comprises a single amino acid substitution with any amino acid at any position other than X 1 or X 2 ; wherein said anti-microbial peptide retains anti-microbial activity with said substitution; and wherein said peptide optionally comprises at least one D-amino acid.

2. The isolated anti-microbial peptide of claim 1 , wherein X 1 and X 2 are biphenylalanine.

3. The isolated anti-microbial peptide of claim 1 , wherein said peptide comprises at least one D-amino acid.

4. The isolated anti-microbial peptide of claim 1 , wherein the amino acids at positions 5, 9, and 13 are D-amino acids.

5. The isolated anti-microbial peptide of claim 1 , wherein said peptide further comprises at least one modification selected from the group consisting of amidation and acetylation.

6. A composition comprising at least one anti-microbial peptide of claim 1 and at least one pharmaceutically acceptable carrier.

7. The composition of claim 6 , further comprising at least one antibiotic.

8. A method for inhibiting a microbial infection in a subject in need thereof, said method comprising administering to said subject the composition of claim 6 .

9. The method of claim 8 , further comprising the administration of at least one additional antibiotic.

10. The method of claim 8 , wherein said microbial infection is a staphylococcal infection.

11. The method of claim 8 , wherein said microbial infection is a methicillin-resistant Staphylococcus aureus (MRSA) infection.

12. An isolated anti-microbial peptide comprising the amino acid sequence selected from the group consisting of SEQ ID NO: 68, SEQ ID NO: 69, and SEQ ID NO: 70.

13. An isolated anti-microbial peptide, wherein the peptide is selected from the group consisting of the peptide consisting of the amino acid sequence of SEQ ID NO: 68, the peptide consisting of the amino acid sequence of SEQ ID NO: 69, and the peptide consisting of the amino acid sequence of SEQ ID NO: 70.

14. The isolated anti-microbial peptide of claim 1 , wherein X 1 and X 2 are each independently selected from the group consisting of trifluoromethylphenylalanine, napthylalanine, and biphenylalanine.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 18, 2015
From: UNIVERSITY OF NEBRASKA MEDICAL CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 035953/0783 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2015
From: WANG, GUANGSHUN
To: BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Reel/Frame 035826/0609 →
Continuity (4)
Continuation In Part 14358340
Provisional Application 61561990 · Nov 21, 2011
Provisional Application 61986191 · Apr 30, 2014
Related Publication 20150259382A1 · Sep 17, 2015